⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.
Pyridostigmine
پیریدوستیگمین
🧠 Nervous SystemCholinesterase inhibitor
🤰 Pregnancy:Use with caution👶 Children:Safety not established 🇮🇷 Registered in Iran⛔ 1 contraindications 🇺🇸 FDA approved generic (ANDA) ANDA211181ATC N07AA02
Market / country: 🇺🇸 USA
Mestinon (US)
🧮 Dose calculator
Myasthenia gravis · Regimen source: FDA Pyridostigmine · Dosage and AdministrationFDA Pyridostigmine · Warnings
⛔ Label: average daily total equivalent to 600 mg (ten 60 mg tablets), spaced for peak effect; mild cases 120–720 mg and severe up to 1,500 mg/day. Poor response may reflect under- or overdosing (cholinergic crisis). FDA Pyridostigmine · Dosage and AdministrationFDA Pyridostigmine · Warnings
🛡️ Safety & information
Contraindications
- ⛔ Mechanical intestinal or urinary obstruction; caution in asthma. FDA Pyridostigmine · Contraindications
Formulations
- 30 mg tablet — tablet 🇺🇸 USA FDA Pyridostigmine · Dosage and Administration
👥 Special populations
- 🤰 PregnancyUse with caution
Darooyab: category B — only if benefit outweighs risk. Darooyab · G-3053/Pyridostigmine — مصرف در بارداری
“مصرف در بارداری پیریدوستیگمین گروه B قابل استفاده در بارداری:”
- 🤱 BreastfeedingNo data
The source for this drug has no section for this group.
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Pyridostigmine · Pediatric Use
“Safety and effectiveness in pediatric patients have not been established.”
- 👴 Older adultsNo data
The source for this drug has no section for this group.
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA211181
- DailyMed (FDA label)FDA Pyridostigmine
- MedlinePlus (NIH)Pyridostigmine
- WHO ATC/DDDN07AA02
- Darooyab (Iran)Pyridostigmine
🇮🇷 Registered in Iran Darooyab · G-3053/Pyridostigmine
Dosage forms with Iranian generic codes, per Darooyab.
- 01079 · PYRIDOSTIGMINE BROMIDE 10MG TAB · قرص پیریدوستیگمین بروماید ۱۰ میلیگرم
- 01080 · PYRIDOSTIGMINE BROMIDE 60MG TAB · قرص پیریدوستیگمین بروماید ۶۰ میلیگرم
- 51600 · PYRIDOSTIGMINE BROMIDE TABLET, EXTENDED RELEASE ORAL 180 mg · قرص آهستهرهش پیریدوستیگمین بروماید ۱۸۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Pyridostigmine · Dosage and AdministrationFDA Pyridostigmine · WarningsFDA Pyridostigmine · ContraindicationsFDA Pyridostigmine · SPL approval / marketing categoryFDA Pyridostigmine · Pediatric Use
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-3053/PyridostigmineDarooyab · G-3053/Pyridostigmine — مصرف در بارداری
- Clinical review⚠ Unverified